SAREPTA THERAPEUTICS, INC. Gain (Loss) on Disposition of Other Assets
SAREPTA THERAPEUTICS, INC. (SRPT) reported Gain (Loss) on Disposition of Other Assets of -$322.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2023-08-02
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for the quarter ending 2022-12-31 was -$5.31M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for the quarter ending 2022-09-30 was -$86.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for the quarter ending 2021-12-31 was -$8.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for the quarter ending 2021-09-30 was -$106.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for fiscal 2022 was -$10.77M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for fiscal 2021 was -$456.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of other assets for fiscal 2020 was -$85.00K.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$322.00K 10-Q · filed 2023-08-02 | |||
| 2022-12-31 | -$5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$5.40M derived: sum of 2 quarters · filed 2023-02-28 | -$10.77M 10-K · filed 2023-02-28 | |
| 2022-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$5.46M 10-Q · filed 2022-11-02 | ||
| 2022-06-30 | -$5.37M 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$114.00K derived: sum of 2 quarters · filed 2023-02-28 | -$456.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$448.00K 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | -$342.00K 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | -$85.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |